Passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a Chance to Celebrate and Reflect
- 2 March 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 32 (4), 774-776
- https://doi.org/10.1681/asn.2020121811
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current EraJournal of the American Society of Nephrology, 2019
- Kidney transplant graft outcomes in 379 257 recipients on 3 continentsAmerican Journal of Transplantation, 2018
- Penny Wise, Pound Foolish? Coverage Limits on Immunosuppression after Kidney TransplantationThe New England Journal of Medicine, 2012
- Drug Coverage for Transplantation Turns into Political FootballClinical Journal of the American Society of Nephrology, 2010
- Payment for Immunosuppression After Organ TransplantationJAMA, 2000